EMPOWER for Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
CancerEMPOWER - Behavioral
Eligibility
15 - 39
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a digital health intervention to improve wellbeing in young adult cancer survivors. The goal is to learn more about how to promote wellness and manage health-related quality of life among this population.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
12-week videoconferencing behavioural support intervention to promote physical activity behaviour
1
Varenicline Tartrate
1
ZoeInsights Application Arm

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Baseline up to 4 months after intervention

Month 4
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Questionnaire
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Questionnaire
Patient-Reported Outcomes Measurement Information System (PROMIS) Life Satisfaction Questionnaire
Patient-Reported Outcomes Measurement Information System (PROMIS) Positive Affect Computer Adaptive Test (CAT) Questionnaire

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
12-week videoconferencing behavioural support intervention to promote physical activity behaviour
2
Varenicline Tartrate
1
ZoeInsights Application Arm

Trial Design

32 Treatment Groups

Condition 7
1 of 32
Condition 18
1 of 32
Condition 10
1 of 32
Condition 4
1 of 32
Condition 17
1 of 32
Condition 16
1 of 32
Condition 8
1 of 32
Condition 1
1 of 32
Condition 15
1 of 32
Condition 5
1 of 32
Condition 31
1 of 32
Condition 9
1 of 32
Condition 24
1 of 32
Condition 26
1 of 32
Condition 13
1 of 32
Condition 22
1 of 32
Condition 23
1 of 32
Condition 6
1 of 32
Condition 19
1 of 32
Condition 11
1 of 32
Condition 3
1 of 32
Condition 27
1 of 32
Condition 30
1 of 32
Condition 29
1 of 32
Condition 32
1 of 32
Condition 2
1 of 32
Condition 12
1 of 32
Condition 14
1 of 32
Condition 21
1 of 32
Condition 28
1 of 32
Condition 25
1 of 32
Condition 20
1 of 32

Experimental Treatment

352 Total Participants · 32 Treatment Groups

Primary Treatment: EMPOWER · No Placebo Group · N/A

Condition 7
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 18
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 10
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 4
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 17
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 16
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 8
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 1
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 15
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 5
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 31
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 9
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 24
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 26
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 13
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 22
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 23
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 6
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 19
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 11
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 3
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 27
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 30
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 29
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 32
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 2
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 12
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 14
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 21
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 28
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 25
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Condition 20
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EMPOWER
2022
N/A
~40

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline up to 4 months after intervention

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,125 Previous Clinical Trials
1,126,831 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,084 Previous Clinical Trials
41,141,294 Total Patients Enrolled
John M Salsman, Ph.DPrincipal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 15 - 39 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are able to read and understand English.
You have a history of a cancer diagnosis.
You have been diagnosed with cancer at a younger age than the average person of your age.
You have received active treatment for breast cancer within the past 5 years.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top